Corporate Partners

Research Study Planning & Optimization

Intelligently designed protocols and study plans optimize efficiency, efficacy, and safety. Likewise, experimental designs minimize study attrition or other pitfalls to achieve your project objectives.

Our experts will guide you in effective decision-making for HCT, other cellular therapy, and gene therapy studies.

Our services include:

• Protocol design or review
• Statistical support

Regulatory Consulting

Our team includes experts in all aspects of HCT, other cellular therapies, and gene therapies. We will leverage years of direct patient care experience and unparalleled insights from more than >1,750 publications and ~250 ongoing studies and clinical trials.

Our services include:

• Support services for managing regulatory obligations.
• Expertise in providing reports, consultations, and other services in order to address regulatory requirements and navigate and respond to evolving needs and requests.

Real-World Data

Harness robust data for your studies with the most comprehensive real-world data available for patients receiving HCT, other cellular therapies, and gene therapies in the US.

Our experts apply real-world solutions to further the research field, propelling us forward to improve patient care and outcomes while supporting our corporate partners.

Our services include:

• Retrospective or prospective data collection
• Custom de-identified datasets
• Patient-reported outcomes | Our researchers design studies that continuously assess how to improve patient-provider communication, assist with clinical decision-making, improve patient satisfaction, enhance patient outcomes, and ensure a better quality of care from a healthcare system perspective

Real-World Evidence

If you're seeking robust solutions regarding the usage and benefits of your product, our experts can support your efforts by designing custom solutions to assess your product's potential benefits or risks!

Our services include:

• Observational clinical studies
• Post-authorization studies | Regulatory agencies require a post-authorization study at the time of approval. Our project designs help you assure continued safety, effectiveness, and risk identification
  • Study planning and design
  • Accrual and analysis reports
  • Sample collection and biorepository services
• Control arms and contemporaneous control cohorts
• Matched controls
• Cross-sectional and longitudinal studies
• Landmark analyses
• Retrospective and prospective study reports

Corporate Membership Program

Choose valuable benefits from five different membership levels, including access to the most comprehensive blood and bone marrow transplantation information and additional specialized corporate services to meet your project objectives.

Access Corporate Membership Program resources today!